U
XTL Biopharmaceuticals Ltd. XTLB
$2.18 $0.0251.16%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 03/31/2023 12/31/2022
Revenue -- -- --
Total Other Revenue -- -- --
Total Revenue -- -- --
Cost of Revenue -- -- --
Gross Profit -- -- --
SG&A Expenses 194.00K 238.00K 219.00K
Depreciation & Amortization -- -- --
Other Operating Expenses -- -- --
Total Operating Expenses 200.00K 251.00K 225.00K
Operating Income -200.00K -251.00K -225.00K
Income Before Tax -284.00K -919.00K -748.00K
Income Tax Expenses -- -- --
Earnings from Continuing Operations -284.00K -919.00K -748.00K
Earnings from Discontinued Operations -- -- --
Extraordinary Item & Accounting Change -- -- --
Minority Interest in Earnings -- -- --
Net Income -284.00K -919.00K -748.00K
EBIT -200.00K -251.00K -225.00K
EBITDA -199.80K -250.80K -224.80K
EPS Basic 0.00 0.00 0.00
Normalized Basic EPS 0.00 -- 0.00
EPS Diluted 0.00 0.00 0.00
Normalized Diluted EPS 0.00 -- 0.00
Average Basic Shares Outstanding 544.91M 544.91M 544.91M
Average Diluted Shares Outstanding 544.91M 544.91M 544.91M
Dividend Per Share -- -- --
Payout Ratio -- -- --
Weiss Ratings